Chemours Research Development vs Non Recurring Analysis

CC Stock

USD 21.53 0.73 3.51%

Chemours financial indicator trend analysis is way more than just evaluating Chemours prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Chemours is a good investment. Please check the relationship between Chemours Research Development and its Non Recurring accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chemours Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

Research Development vs Non Recurring

Research Development vs Non Recurring Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Chemours Research Development account and Non Recurring. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Chemours' Research Development and Non Recurring is -0.39. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Non Recurring in the same time period over historical financial statements of Chemours Co, assuming nothing else is changed. The correlation between historical values of Chemours' Research Development and Non Recurring is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of Chemours Co are associated (or correlated) with its Non Recurring. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Recurring has no effect on the direction of Research Development i.e., Chemours' Research Development and Non Recurring go up and down completely randomly.

Correlation Coefficient

-0.39

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Research Development

Non Recurring

Most indicators from Chemours' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Chemours current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chemours Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

At present, Chemours' Enterprise Value Multiple is projected to increase significantly based on the last few years of reporting.

	2021	2022	2023	2024 (projected)
Gross Profit	1.4B	1.6B	1.3B	1.2B
Total Revenue	6.3B	6.8B	6.0B	5.1B

Gross Profit Total Revenue

Chemours fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Property Plant And Equipment Net	Current Deferred Revenue	Accounts Payable	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Net Receivables	Good Will	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment
Common Stock Shares Outstanding		-0.67	-0.73	-0.64	0.36	-0.63	-0.71	-0.79	-0.43	-0.79	-0.21	-0.6	-0.41	0.85	0.73	-0.46	-0.68	-0.82	0.63	-0.51	-0.69	-0.52	0.16	0.61	0.47	-0.7
Total Assets	-0.67		0.76	0.83	-0.71	0.86	0.76	0.47	0.69	0.86	0.37	0.87	0.84	-0.5	-0.91	0.86	0.63	0.54	-0.83	0.9	0.72	0.95	-0.65	-0.64	-0.83	0.76
Other Current Liab	-0.73	0.76		0.83	-0.71	0.77	0.47	0.82	0.45	0.58	0.3	0.73	0.71	-0.45	-0.79	0.72	0.36	0.83	-0.7	0.77	0.5	0.76	-0.65	-0.67	-0.75	0.54
Total Current Liabilities	-0.64	0.83	0.83		-0.59	0.84	0.43	0.68	0.7	0.58	0.4	0.92	0.64	-0.39	-0.89	0.66	0.63	0.67	-0.73	0.75	0.79	0.86	-0.49	-0.68	-0.65	0.52
Total Stockholder Equity	0.36	-0.71	-0.71	-0.59		-0.82	-0.47	-0.23	-0.24	-0.54	-0.35	-0.67	-0.97	0.27	0.71	-0.96	-0.08	-0.26	0.75	-0.95	-0.33	-0.72	0.92	0.47	0.97	-0.46
Other Liab	-0.63	0.86	0.77	0.84	-0.82		0.58	0.5	0.55	0.72	0.5	0.9	0.85	-0.42	-0.89	0.87	0.58	0.51	-0.77	0.91	0.71	0.84	-0.67	-0.61	-0.85	0.62
Property Plant And Equipment Net	-0.71	0.76	0.47	0.43	-0.47	0.58		0.31	0.31	0.97	0.02	0.47	0.6	-0.69	-0.59	0.64	0.51	0.42	-0.65	0.63	0.46	0.53	-0.32	-0.53	-0.58	0.96
Current Deferred Revenue	-0.79	0.47	0.82	0.68	-0.23	0.5	0.31		0.39	0.42	0.19	0.5	0.22	-0.48	-0.53	0.25	0.49	0.97	-0.41	0.33	0.46	0.44	-0.13	-0.6	-0.28	0.41
Accounts Payable	-0.43	0.69	0.45	0.7	-0.24	0.55	0.31	0.39		0.48	0.65	0.69	0.37	-0.08	-0.69	0.39	0.78	0.38	-0.55	0.46	0.73	0.72	-0.24	-0.51	-0.39	0.33
Non Current Assets Total	-0.79	0.86	0.58	0.58	-0.54	0.72	0.97	0.42	0.48		0.24	0.65	0.67	-0.71	-0.74	0.71	0.64	0.5	-0.72	0.72	0.62	0.66	-0.39	-0.63	-0.66	0.92
Non Currrent Assets Other	-0.21	0.37	0.3	0.4	-0.35	0.5	0.02	0.19	0.65	0.24		0.6	0.36	0.01	-0.49	0.36	0.46	0.11	-0.31	0.38	0.47	0.4	-0.36	-0.41	-0.39	-0.08
Other Assets	-0.6	0.87	0.73	0.92	-0.67	0.9	0.47	0.5	0.69	0.65	0.6		0.74	-0.44	-0.93	0.76	0.65	0.51	-0.72	0.82	0.84	0.88	-0.59	-0.66	-0.74	0.48
Long Term Debt	-0.41	0.84	0.71	0.64	-0.97	0.85	0.6	0.22	0.37	0.67	0.36	0.74		-0.33	-0.78	1.0	0.22	0.28	-0.8	0.99	0.42	0.83	-0.91	-0.5	-0.99	0.58
Net Receivables	0.85	-0.5	-0.45	-0.39	0.27	-0.42	-0.69	-0.48	-0.08	-0.71	0.01	-0.44	-0.33		0.56	-0.37	-0.46	-0.54	0.5	-0.39	-0.55	-0.31	0.07	0.39	0.36	-0.59
Good Will	0.73	-0.91	-0.79	-0.89	0.71	-0.89	-0.59	-0.53	-0.69	-0.74	-0.49	-0.93	-0.78	0.56		-0.81	-0.62	-0.57	0.81	-0.86	-0.87	-0.9	0.61	0.68	0.81	-0.59
Non Current Liabilities Total	-0.46	0.86	0.72	0.66	-0.96	0.87	0.64	0.25	0.39	0.71	0.36	0.76	1.0	-0.37	-0.81		0.27	0.31	-0.82	0.99	0.47	0.84	-0.89	-0.52	-0.99	0.62
Inventory	-0.68	0.63	0.36	0.63	-0.08	0.58	0.51	0.49	0.78	0.64	0.46	0.65	0.22	-0.46	-0.62	0.27		0.49	-0.48	0.34	0.79	0.54	0.05	-0.37	-0.23	0.52
Other Current Assets	-0.82	0.54	0.83	0.67	-0.26	0.51	0.42	0.97	0.38	0.5	0.11	0.51	0.28	-0.54	-0.57	0.31	0.49		-0.46	0.38	0.49	0.49	-0.18	-0.64	-0.33	0.51
Other Stockholder Equity	0.63	-0.83	-0.7	-0.73	0.75	-0.77	-0.65	-0.41	-0.55	-0.72	-0.31	-0.72	-0.8	0.5	0.81	-0.82	-0.48	-0.46		-0.84	-0.58	-0.78	0.56	0.59	0.83	-0.62
Total Liab	-0.51	0.9	0.77	0.75	-0.95	0.91	0.63	0.33	0.46	0.72	0.38	0.82	0.99	-0.39	-0.86	0.99	0.34	0.38	-0.84		0.54	0.88	-0.86	-0.57	-0.98	0.63
Property Plant And Equipment Gross	-0.69	0.72	0.5	0.79	-0.33	0.71	0.46	0.46	0.73	0.62	0.47	0.84	0.42	-0.55	-0.87	0.47	0.79	0.49	-0.58	0.54		0.68	-0.19	-0.61	-0.45	0.47
Total Current Assets	-0.52	0.95	0.76	0.86	-0.72	0.84	0.53	0.44	0.72	0.66	0.4	0.88	0.83	-0.31	-0.9	0.84	0.54	0.49	-0.78	0.88	0.68		-0.71	-0.57	-0.82	0.57
Short Term Debt	0.16	-0.65	-0.65	-0.49	0.92	-0.67	-0.32	-0.13	-0.24	-0.39	-0.36	-0.59	-0.91	0.07	0.61	-0.89	0.05	-0.18	0.56	-0.86	-0.19	-0.71		0.35	0.91	-0.31
Intangible Assets	0.61	-0.64	-0.67	-0.68	0.47	-0.61	-0.53	-0.6	-0.51	-0.63	-0.41	-0.66	-0.5	0.39	0.68	-0.52	-0.37	-0.64	0.59	-0.57	-0.61	-0.57	0.35		0.51	-0.55
Common Stock	0.47	-0.83	-0.75	-0.65	0.97	-0.85	-0.58	-0.28	-0.39	-0.66	-0.39	-0.74	-0.99	0.36	0.81	-0.99	-0.23	-0.33	0.83	-0.98	-0.45	-0.82	0.91	0.51		-0.55
Property Plant Equipment	-0.7	0.76	0.54	0.52	-0.46	0.62	0.96	0.41	0.33	0.92	-0.08	0.48	0.58	-0.59	-0.59	0.62	0.52	0.51	-0.62	0.63	0.47	0.57	-0.31	-0.55	-0.55

Click cells to compare fundamentals

Chemours Account Relationship Matchups

Chemours fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	164.8M	166.3M	168.7M	158.3M	148.9M	140.1M
Total Assets	7.3B	7.1B	7.6B	7.6B	8.3B	7.5B
Other Current Liab	477M	449M	545M	475M	1.2B	1.3B
Total Current Liabilities	1.5B	1.4B	1.9B	1.9B	2.5B	1.8B
Total Stockholder Equity	689M	813M	1.1B	1.1B	737M	1.1B
Other Liab	751M	626M	707M	854M	982.1M	711.9M
Property Plant And Equipment Net	3.9B	3.7B	3.4B	3.4B	3.5B	3.6B
Accounts Payable	923M	820M	1.2B	1.2B	1.1B	1.1B
Non Current Assets Total	4.5B	4.4B	4.2B	4.4B	4.4B	4.4B
Non Currrent Assets Other	391M	252M	310M	573M	374M	416.1M
Other Assets	292M	405M	547M	725M	833.8M	424.1M
Long Term Debt	4.0B	4.0B	3.7B	3.6B	4.0B	3.2B
Net Receivables	674M	511M	720M	626M	610M	602.4M
Liabilities And Stockholders Equity	7.3B	7.1B	7.6B	7.6B	8.3B	7.5B
Non Current Liabilities Total	5.0B	4.8B	4.6B	4.6B	5.0B	4.1B
Inventory	1.1B	939M	1.1B	1.4B	1.4B	1.2B
Other Current Assets	81M	156M	150M	82M	670M	703.5M
Other Stockholder Equity	(213M)	(182M)	(303M)	(722M)	(773M)	(734.4M)
Total Liab	6.6B	6.3B	6.5B	6.5B	7.5B	6.0B
Property Plant And Equipment Gross	3.9B	3.7B	9.2B	9.4B	9.6B	5.2B
Total Current Assets	2.8B	2.6B	3.3B	3.2B	3.8B	3.0B
Accumulated Other Comprehensive Income	(349M)	(310M)	(364M)	(343M)	(274M)	(287.7M)
Short Term Debt	134M	78M	84M	141M	106M	97.8M
Intangible Assets	28M	21M	14M	6M	3M	2.9M
Property Plant Equipment	3.9B	3.5B	3.4B	3.2B	3.6B	3.5B
Net Tangible Assets	515M	646M	973M	992M	892.8M	710.5M
Retained Earnings	1.2B	1.3B	1.7B	2.2B	1.8B	1.1B
Cash	943M	1.1B	1.5B	1.1B	1.2B	1.1B
Deferred Long Term Liab	148M	36M	49M	61M	54.9M	96.1M
Long Term Investments	162M	167M	169M	175M	158M	171.6M
Short Long Term Debt	13M	134M	21M	25M	51M	41.5M
Short Long Term Debt Total	4.4B	4.3B	3.9B	3.8B	4.3B	4.4B
Net Debt	3.5B	3.2B	2.5B	2.7B	3.1B	2.4B
Cash And Short Term Investments	943M	1.1B	1.5B	1.1B	1.2B	1.2B
Retained Earnings Total Equity	1.2B	1.3B	1.7B	2.2B	2.5B	2.6B
Long Term Debt Total	4.0B	4.0B	3.7B	3.6B	3.2B	3.1B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

How To Invest In Chemours

Details

Is Chemours Stock a good investment?

Details

What is Chemours' Net Worth?

Details

Largest Diversified Chemicals Companies

View

Largest Specialty Chemicals Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chemours Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Is Diversified Chemicals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chemours. If investors know Chemours will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chemours listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.65)

Dividend Share

Earnings Share

0.5

Revenue Per Share

38.519

Quarterly Revenue Growth

0.009

The market value of Chemours is measured differently than its book value, which is the value of Chemours that is recorded on the company's balance sheet. Investors also form their own opinion of Chemours' value that differs from its market value or its book value, called intrinsic value, which is Chemours' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemours' market value can be influenced by many factors that don't directly affect Chemours' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Chemours' value and its price as these two are different measures arrived at by different means. Investors typically determine if Chemours is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemours' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Chemours Research Development vs Non Recurring Analysis

Research Development vs Non Recurring

Research Development vs Non Recurring Correlation Analysis

Correlation Coefficient

Research Development

Non Recurring

Chemours fundamental ratios Correlations

Chemours Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Chemours fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Liabilities Total	+ 1.0	Long Term Debt
Total Liab	+ 0.99	Long Term Debt
Total Liab	+ 0.99	Non Current Liabilities Total
Common Stock	+ 0.97	Total Stockholder Equity
Non Current Assets Total	+ 0.97	Property Plant And Equipment Net
Other Current Assets	+ 0.97	Current Deferred Revenue

Common Stock	- 0.99	Non Current Liabilities Total
Common Stock	- 0.99	Long Term Debt
Common Stock	- 0.98	Total Liab
Long Term Debt	- 0.97	Total Stockholder Equity
Non Current Liabilities Total	- 0.96	Total Stockholder Equity
Total Liab	- 0.95	Total Stockholder Equity